High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus

Internal Medicine

Volumn 35, Issue 5, 1996, Pages 367-372

  Funauchi, Masanori ^a   Ikoma, Shinya ^a   Enomoto, Hiroshi ^a   Ohno, Motoki ^a   Kinoshita, Kohji ^a   Horiuchi, Atsushi ^a   Kurata, Noriyuki ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

dextran sulfate column; lupus nephritis; sodium chloride

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXTRAN SULFATE; DNA ANTIBODY; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; IMMUNOADSORPTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029980225     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.367     Document Type: Article

References (15)

1. Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278: 533, 1968.
2. Bruneau C, Benveniste J. Circulating DNA: anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation. J Clin Invest 64: 191, 1979.
3. Gauthier VJ, Mannik M. A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition in glomeruli. J Immunol 145: 3348, 1990.
4. Vlahakos DV, Foster MH, Adams S, et al. Anti-DNA antibodies form immune deposit at distinct glomerular and vascular sites. Kidney Int 41: 1690, 1992.
5. Hashimoto H, Tsuda H, Kanai Y, et al. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J Rheumatol 18: 545, 1991.
6. Suzuki K, Hara M, Harigai M, et al. Continuous removal of anti-DNA antibody using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus using a new extracorporeal immunoadsorption system. Arthritis Rheum 34: 1546, 1991.
7. Minoda M, Funauchi M, Horiuchi A. Clinical evaluation of selective adsorption therapy for anti-DNA antibody in patients with systemic lupus erythematosus. Jpn J Apheresis 13: 125, 1994.
8. Funauchi M, Ohno M, Minoda M, Horiuchi A. Three cases of systemic lupus erythematosus treated by immunoadsorbent plasma perfusion with a dextransulfate column. Therapeutic Plasmapheresis 10: 214, 1992.
9. Wold RT, Young FE, Tan EM, Farr, RS. Deoxyribonucleic acid antibody, a method to detect its primary interaction with deoxyribonucleic acid. Science 161: 806, 1968.
10. Fellkamp TEW, Kirkwood TBL, Maini RN, Aarden LA. The first international standard for antibodies to double stranded DNA. Ann Rheum Dis 47: 740, 1988.
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271, 1982.
12. Smeenk RJT, van Rooijen A, Swaak TJG. Dissociation studies of DNA/ anti-DNA complexes in relation to anti-DNA avidity. J Immunol Methods 109: 27, 1988.
13. Yoshida M, Yoshida H, Muso E, et al. Avidity of anti-DNA antibodies and its clinical significance in patients with SLE. Jpn Arch Int Med 34: 89, 1987.
14. McGrath H Jr, Biunda JJ Jr. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus. Arthritis Rheum 28: 425, 1985.
15. Geshwin ME, Steinberg AD. Qualitative characteristics of anti-DNA antibodies in lupus nephritis. Arthritis Rheum 17: 947, 1974.